Literature DB >> 29191386

MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23.

Hongyan Xue1, Guo-Yan Tian2.   

Abstract

Accumulating documents have revealed that microRNAs (miRNAs) play critical roles in the development and progression of tumors. MiR-429 has been reported to be involved in regulating various cellular processes. However, its biological role and underlying mechanism in hepatocellular carcinoma (HCC) still need to be further studied. The present study aimed to investigate the function of miR-429 in the progression of HCC. In terms of this paper, it was found that miR-429 was down-regulated in HCC tissues and cells. After being transfected with miR-429 mimics, miR-429 decreased the migratory capacity and reversed the EMT to MET in HCC cells. RAB23 was confirmed as a target of miR-429. Rescue assays further verified that the function of miR-429 in HCC cells was exerted through targeting RAB23. In general, it was concluded that the signal pathway miR-429/RAB23 might be a potential target for HCC treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; HCC; Metastasis; MiR-429; RAB23

Mesh:

Substances:

Year:  2017        PMID: 29191386     DOI: 10.1016/j.abb.2017.11.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

1.  Knockdown of miR-429 Attenuates Aβ-Induced Neuronal Damage by Targeting SOX2 and BCL2 in Mouse Cortical Neurons.

Authors:  Shengqi Fu; Jiewen Zhang; Shuling Zhang
Journal:  Neurochem Res       Date:  2018-09-27       Impact factor: 3.996

2.  Identification of MSC-AS1, a novel lncRNA for the diagnosis of laryngeal cancer.

Authors:  Yudong Liu; Wenxia Meng; Huan Cao; Baoshan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-20       Impact factor: 2.503

3.  MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.

Authors:  Zhengming Su; Ganggang Jiang; Jinlan Chen; Xing Liu; Haibo Zhao; Zhiyuan Fang; Yongzhong He; Xianhan Jiang; Guibin Xu
Journal:  Mol Clin Oncol       Date:  2019-10-25

4.  LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway.

Authors:  Liping Wu; Yongcun Liu; Cheng Guo; Yuan Shao
Journal:  Cancer Cell Int       Date:  2020-07-09       Impact factor: 5.722

5.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

Review 6.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

7.  Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines.

Authors:  Zhi Zhang; Cheng-Zu He; Ya-Qin Qin; Jian-Jun Liao; Shang-Tao Huang; Steven Mo; Hong-Mian Li; Jian-Yan Lin
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

Review 8.  Autophagy and Extracellular Vesicles, Connected to rabGTPase Family, Support Aggressiveness in Cancer Stem Cells.

Authors:  Aude Brunel; Gaëlle Bégaud; Clément Auger; Stéphanie Durand; Serge Battu; Barbara Bessette; Mireille Verdier
Journal:  Cells       Date:  2021-05-27       Impact factor: 6.600

9.  miRNA-429 suppresses osteogenic differentiation of human adipose-derived mesenchymal stem cells under oxidative stress via targeting SCD-1.

Authors:  Changgong Lan; Lizhen Long; Kegong Xie; Jia Liu; Landao Zhou; Shengcai Pan; Junqing Liang; Zhenyang Tu; Ziran Gao; Yujin Tang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

10.  MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL.

Authors:  Wei Zou; Jun Cheng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.